Literature DB >> 22119145

Stem cells as the root of pancreatic ductal adenocarcinoma.

Anamaria Balic1, Jorge Dorado, Mercedes Alonso-Gómez, Christopher Heeschen.   

Abstract

Emerging evidence suggests that stem cells play a crucial role not only in the generation and maintenance of different tissues, but also in the development and progression of malignancies. For the many solid cancers, it has now been shown that they harbor a distinct subpopulation of cancer cells that bear stem cell features and therefore, these cells are termed cancer stem cells (CSC) or tumor-propagating cells. CSC are exclusively tumorigenic and essential drivers for tumor progression and metastasis. Moreover, it has been shown that pancreatic ductal adenocarcinoma does not only contain one homogeneous population of CSC rather than diverse subpopulations that may have evolved during tumor progression. One of these populations is called migrating CSC and can be characterized by CXCR4 co-expression. Only these cells are capable of evading the primary tumor and traveling to distant sites such as the liver as the preferred site of metastatic spread. Clinically even more important, however, is the observation that CSC are highly resistant to chemo- and radiotherapy resulting in their relative enrichment during treatment and rapid relapse of disease. Many laboratories are now working on the further in-depth characterization of these cells, which may eventually allow for the identification of their Achilles heal and lead to novel treatment modalities for fighting this deadly disease. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22119145     DOI: 10.1016/j.yexcr.2011.11.007

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  22 in total

1.  Intracellular autofluorescence: a biomarker for epithelial cancer stem cells.

Authors:  Irene Miranda-Lorenzo; Jorge Dorado; Enza Lonardo; Sonia Alcala; Alicia G Serrano; Jenifer Clausell-Tormos; Michele Cioffi; Diego Megias; Sladjana Zagorac; Anamaria Balic; Manuel Hidalgo; Mert Erkan; Joerg Kleeff; Aldo Scarpa; Bruno Sainz; Christopher Heeschen
Journal:  Nat Methods       Date:  2014-09-28       Impact factor: 28.547

2.  CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide.

Authors:  Sulagna Banerjee; Alice Nomura; Veena Sangwan; Rohit Chugh; Vikas Dudeja; Selwyn M Vickers; Ashok Saluja
Journal:  Clin Cancer Res       Date:  2014-03-14       Impact factor: 12.531

Review 3.  Common stemness regulators of embryonic and cancer stem cells.

Authors:  Christiana Hadjimichael; Konstantina Chanoumidou; Natalia Papadopoulou; Panagiota Arampatzi; Joseph Papamatheakis; Androniki Kretsovali
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

4.  Nicotine induces self-renewal of pancreatic cancer stem cells via neurotransmitter-driven activation of sonic hedgehog signalling.

Authors:  Mohammed H Al-Wadei; Jheelam Banerjee; Hussein A N Al-Wadei; Hildegard M Schuller
Journal:  Eur J Cancer       Date:  2015-12-12       Impact factor: 9.162

Review 5.  Pancreatic cancer stem cell markers and exosomes - the incentive push.

Authors:  Sarah Heiler; Zhe Wang; Margot Zöller
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

6.  Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance.

Authors:  Hyung-Seok Kim; Seon-Young Yoo; Kyung-Tae Kim; Jong-Tae Park; Hyun-Jong Kim; Jung-Chul Kim
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

Review 7.  Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challenges.

Authors:  Sheng Pan; Teresa A Brentnall; Kimberly Kelly; Ru Chen
Journal:  Proteomics       Date:  2013-01-07       Impact factor: 3.984

8.  Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation.

Authors:  Jia Sun; Jing Yan; Huai-Yu Qiao; Fu-Ying Zhao; Chao Li; Jing-Yi Jiang; Bao-Qin Liu; Xiao-Na Meng; Hua-Qin Wang
Journal:  Oncogene       Date:  2019-09-09       Impact factor: 9.867

9.  NFκB-Mediated Invasiveness in CD133+ Pancreatic TICs Is Regulated by Autocrine and Paracrine Activation of IL1 Signaling.

Authors:  Alice Nomura; Vineet K Gupta; Patricia Dauer; Nikita S Sharma; Vikas Dudeja; Nipun Merchant; Ashok K Saluja; Sulagna Banerjee
Journal:  Mol Cancer Res       Date:  2017-09-28       Impact factor: 5.852

10.  Impact of diabetes type II and chronic inflammation on pancreatic cancer.

Authors:  Dietmar Zechner; Tobias Radecke; Jonas Amme; Florian Bürtin; Ann-Christin Albert; Lars Ivo Partecke; Brigitte Vollmar
Journal:  BMC Cancer       Date:  2015-02-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.